Weight-loss pill gets quick approval from FDA
Digest more
April 1 (Reuters) - The U.S. Food and Drug Administration on Wednesday clarified its policies on compounded versions of popular GLP-1 drugs, signaling tighter limits on their production as national supply conditions improve.
WASHINGTON — Food and Drug Administration Commissioner Marty Makary recounted his agency’s achievements and acknowledged a “challenging start” to his tenure in a speech to staff on Wednesday afternoon.
Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety